Brind.

Innoviva was identified as the largest shareholder of Armata Pharmaceuticals in August 2025.

1 report, 1 independent Updated Aug 13
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Innoviva was identified as the largest shareholder of Armata Pharmaceuticals in August 2025.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • PR NewswireArmata Pharmaceuticals Announces Second Quarter 2025 Results and Provides Corporate Update Entered into secured credit agreement with Innoviva for $15 million maturing in 2029 Announced positive topl